Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022

Amit Hazan Maintained (BVS) at Hold with Decreased Target to $17 on, Mar 21st, 2022

Amit Hazan of Goldman Sachs, Maintained "Bioventus Inc." (BVS) at Hold with Decreased Target from $19 to $17 on, Mar 21st, 2022.

Amit has made no other calls on BVS in the last 4 months.



There are 2 other peers that have a rating on BVS. Out of the 2 peers that are also analyzing BVS, 0 agree with Amit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Amit


  • Alexander Nowak of "Craig-Hallum" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 15th, 2022
  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Friday, March 11th, 2022